[Moving toward personalized breast cancer screening: The role of Primary Care].

Avances hacia el cribado personalizado del cáncer de mama: el papel de la Atención Primaria.
Breast cancer Cribado Cáncer de mama Medicina de precisión Polimorfismos Polymorphisms Precision medicine Screening

Journal

Atencion primaria
ISSN: 1578-1275
Titre abrégé: Aten Primaria
Pays: Spain
ID NLM: 9111075

Informations de publication

Date de publication:
05 2022
Historique:
received: 06 12 2021
accepted: 11 01 2022
pubmed: 28 4 2022
medline: 26 5 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Breast cancer is the leading cause of death in the world among women. The Spanish National Health System (SNHS) introduced population-based breast cancer screening in 1990. As in most European programs, risk is identified on the basis of age and a mammogram is offered every two years to women aged 50-69 years. Scientific evidence is moving toward personalized screening, based on individual risk. This article presents the clinical trials that will evaluate the efficacy of personalized screening and some studies carried out in our environment on the effect of informing women of the benefits and adverse effects of screening or the acceptability and feasibility of offering personalized screening, in the Shared Decision Making context. The Preventive Activities and Health Promotion Program can help transform screening in our SNHS.

Identifiants

pubmed: 35477080
pii: S0212-6567(22)00008-7
doi: 10.1016/j.aprim.2022.102288
pmc: PMC9061619
pii:
doi:

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

102288

Informations de copyright

Copyright © 2022 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.

Références

PLoS One. 2019 Mar 26;14(3):e0214057
pubmed: 30913217
BMJ Open. 2013 Apr 22;3(4):
pubmed: 23610383
Cancers (Basel). 2021 Aug 18;13(16):
pubmed: 34439302
NPJ Breast Cancer. 2017 Sep 13;3:34
pubmed: 28944288
Breast Cancer Res. 2020 Feb 17;22(1):21
pubmed: 32066492
J Natl Cancer Inst. 2017 Jan 27;109(5):
pubmed: 28130475
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
J Clin Oncol. 2015 Oct 1;33(28):3137-43
pubmed: 26282663
BMC Med Inform Decis Mak. 2013;13 Suppl 2:S10
pubmed: 24624970
CMAJ. 2018 Dec 10;190(49):E1441-E1451
pubmed: 30530611
JAMA. 2015 Oct 20;314(15):1599-614
pubmed: 26501536
Aten Primaria. 1999 Dec;24 Suppl 1:76-98
pubmed: 10666927
Aten Primaria. 2020 Nov;52 Suppl 2:44-69
pubmed: 33388117
Patient Educ Couns. 2021 Aug;104(8):1933-1944
pubmed: 33581968
Aten Primaria. 2020 Nov;52 Suppl 2:161-172
pubmed: 33388114
PLoS One. 2019 Dec 16;14(12):e0226352
pubmed: 31841563
Nat Rev Clin Oncol. 2020 Nov;17(11):687-705
pubmed: 32555420
Br J Cancer. 2013 Jun 11;108(11):2205-40
pubmed: 23744281
Gac Sanit. 2021 May-Jun;35(3):243-249
pubmed: 32173050

Auteurs

Anna Pons-Rodriguez (A)

ABS Eixample, Institut Català de la Salut, Lleida, España.

Mercè Marzo-Castillejo (M)

Unitat de Suport a la Recerca Metropolitana Sud, IDIAP Jordi Gol, Direcció d'Atenció Primària Costa de Ponent, Institut Català de la Salut, Barcelona, España.

Inés Cruz-Esteve (I)

ABS Primer de Maig, Institut Català de la Salut, Lleida, España.

Gisela Galindo-Ortego (G)

ABS Primer de Maig, Institut Català de la Salut, Lleida, España.

Maria José Hernández-Leal (MJ)

Departament d'Economia, Universitat Rovira i Virgili, Reus, España; Centre de Recerca en Economia i Sostenibilitat (ECO-SOS), Tarragona, España; Grup de Recerca en Anàlisi Estadística i Econòmica en Salut (GRAEES), Lleida y Reus, España.

Montserrat Rué (M)

Grup de Recerca en Anàlisi Estadística i Econòmica en Salut (GRAEES), Lleida y Reus, España; Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida - Institut de Recerca Biomèdica de Lleida (IRB Lleida), Lleida, España. Electronic address: montserrat.rue@udl.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH